Retraction Note: optical imaging medical diagnosis and analysis of drug treatment for endometriosis and the impact of serum VEGF and MMP-9

This document is a retraction note for an article titled “Optical imaging medical diagnosis and analysis of drug treatment for endometriosis and the impact of serum VEGF and MMP-9,” published online in 2024, with citation links to an original 2023 article. The publisher states that, following an investigation covering multiple articles including this one, multiple concerns were raised—specifically that the work was out of scope for the journal, the peer-review process did not follow editorial policy, and there were inappropriate or irrelevant references and/or nonstandard phrases—leading to withdrawal of confidence in the results and conclusions. The authors did not respond to correspondence regarding the retraction. This paper is centrally about endometriosis — it is a retraction notice explicitly tied to a prior article on optical imaging and drug treatment for endometriosis and biomarkers including serum VEGF and MMP-9.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works